Cited by 307Prostate Cancer Diagnosis and TreatmentMRI in cancer diagnosisMedical Imaging Techniques and Applications

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

Heesakkers, Roel AM, Hövels, Anke M, Jager, Gerrit J, van den Bosch, Harrie CM, Witjes, J Alfred, Raat, Hein PJ, Severens, Johan L, Adang, Eddy MM, van der Kaa, Christina Hulsbergen, Fütterer, Jurgen J, Barentsz, Jelle·2008·The Lancet Oncology

DOI 10.1016/s1470-2045(08)70203-1

Open this paper in CoChat — free account

Abstract

Background In patients with prostate cancer who are deemed to be at intermediate or high risk of having nodal metastases, invasive diagnostic pelvic lymph-node dissection (PLND) is the gold standard for the detection of nodal disease. However, a new lymph-node-specific MR-contrast agent ferumoxtran-10 can detect metastases in normal-sized nodes (ie, <8 mm in size) by use of MR lymphoangiography (MRL). In this prospective, multicentre cohort study, we aimed to compare the diagnostic accuracy of MRL with up-to-date multidetector CT (MDCT), and test the hypothesis that a negative MRL finding obviates the need for a PLND.Methods We included consecutive patients with prostate cancer who had an intermediate or high risk (risk of >5% according to routinely used nomograms) of having lymph-node metastases. All patients were assessed by MDCT and MRL, and underwent PLND or fine-needle aspiration biopsy. Imaging results were correlated with histopathology. The primary outcomes were sensitivity, specificity, accuracy, NPV, and PPV of MRL and MDCT. This study is registered with ClinicalTrials.gov, number NCT00185029.Findings The study was done in 11 hospitals in the Netherlands between April 8, 2003, and April 19, 2005. 375 consecutive patients were included. 61 of 375 (16%) patients had lymph-node metastases. Sensitivity was 34% (21 of 61; 95% CI 23-48) for MDCT and 82% (50 of 61; 70-90) for MRL (McNemar's test p<0.05). Specificity was 97% (303 of 314; 94-98) for MDCT and 93% (291 of 314; 89-95) for MRL. Positive predictive value (PPV) was 66% (21 of 32; 47-81) for MDCT and 69% (50 of 73; 56-79) for MRL. Negative predictive value (NPV) was 88% (303 of 343; 84-91) for MDCT and 96% (291 of 302; 93-98) for MRL (McNemar's test p<0.05). Of the 61 patients with lymph-node metastases, 50 were detected by MRL, of which 40 (80%) had metastases in normal-sized lymph nodes. The high sensitivity and NPV of MRL imply that in patients with a negative MRL, the chance of positive lymph nodes is less than 11/302 (4%).Interpretation MRL had significantly higher sensitivity and NPV than MDCT for patients with prostate cancer who had intermediate or high risk of having lymph-node metastases. In such patients, after a negative MRL, the post-test probability of having lymph-node metastases is low enough to omit a PLND.

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(08)70203-1

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Self-citation
The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer
Partin, A. W., Yoo, J. J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,254
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
Hövels, A. M., Heesakkers, R. A. M., Adang, E., Jager, G. J., Strum, S. B., Hoogeveen, Y. L., Severens, J. L., & Barentsz, J. O. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.05.022 · Cited by 956
Self-citation
Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005
Makarov, D. V., Trock, B. J., Humphreys, E. B., Mangold, L. A., Walsh, P. C., Epstein, J. I., & Partin, A. W. (2007) · Urology · doi:10.1016/j.urology.2007.03.042 · Cited by 474
Risk of prostate carcinoma death in patients with lymph node metastasis
Liang Cheng, C., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B. G., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1 · Cited by 359
Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endometrial and Cervical Cancer
Rockall, A., Sohaib, S. A., Harisinghani, M. G., Babar, S. A., Singh, N., Jeyarajah, A., Oram, D. H., Jacobs, I. J., Shepherd, J. H., & Reznek, R. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.166 · Cited by 338
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
Will, O., Purkayastha, S., Chan, C., Athanasiou, T., Darzi, A. W., Gedroyc, W. M. W., & Tekkis, P. P. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70537-4 · Cited by 260
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin, M., Roy, C., Kinkel, K., Thoumas, D., Zaïm, S., Vanel, D., Tuchmann, C., Richard, F., Didier Jacqmin, D., Delcourt, A., et al. (1998) · Radiology · doi:10.1148/radiology.207.3.9609907 · Cited by 259

Show all 40 references

Research works printed but not linked: 1

El Galley, 1998, Evaluation of staging lymphadenectomy in prostate cancer, Urology, 52, 663, 10.1016/S0090-4295(98)00222-2 · DOI

Sorted by citations

Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,759
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
In Vivo Photoacoustic Tomography of Chemicals: High-Resolution Functional and Molecular Optical Imaging at New Depths
Kim, C., Favazza, C. P., & Wang, L. V. (2010) · Chemical Reviews · doi:10.1021/cr900266s · Cited by 807
Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Maurer, T., Gschwend, J. E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., Wester, H., Heck, M. M., Kübler, H. R., Beer, A. J., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.12.025 · Cited by 778
Current use of PSMA–PET in prostate cancer management
Maurer, T., Eiber, M. J., Schwaiger, M., & Gschwend, J. E. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.26 · Cited by 613
Pelvic Lymph Node Dissection in Prostate Cancer
Briganti, A., Blute, M. L., Eastham, J. H., Graefen, M., Heidenreich, A., Karnes, J. R., Montorsi, F., & Studer, U. E. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.012 · Cited by 507
Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
Gandaglia, G., Karakiewicz, P. I., Briganti, A., Passoni, N. M., Schiffmann, J., Trudeau, V., Graefen, M., Montorsi, F., & Sun, M. (2014) · European Urology · doi:10.1016/j.eururo.2014.07.020 · Cited by 340
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Lecouvet, F. E., Mouedden, J. E., Collette, L., Coche, E., Danse, E. M., Jamar, F., Machiels, J., Berg, B. V., Omoumi, P., & TOMBAL, B. F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.020 · Cited by 301
Magnetic particle imaging: current developments and future directions
Panagiotopoulos, N., Vogt, F., Barkhausen, J., Buzug, T. M., Duschka, R. L., Lüdtke-Buzug, K., Ahlborg, M., Bringout, G., Debbeler, C., Gräser, M., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s70488 · Cited by 289
Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications—A Systematic Review of the Literature
Ploussard, G., Briganti, A., TAILLE, A. D. L., Haese, A., Heidenreich, A., Menon, M., Sulser, T., Tewari, A. K., & Eastham, J. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.057 · Cited by 259
Lymphatic Metastases from Pelvic Tumors: Anatomic Classification, Characterization, and Staging
McMahon, C. J., Rofsky, N. M., & Pedrosa, I. (2009) · Radiology · doi:10.1148/radiol.2541090361 · Cited by 257
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging
Wáng, Y. X. J., & Idée, J.-M. (2017) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2017.02.09 · Cited by 247
Inorganic nanoparticle-based contrast agents for molecular imaging
Cho, E. C., Glaus, C., Chen, J., Welch, M. J., & Younan Xia, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.004 · Cited by 252
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Eiber, M. J., Fendler, W. P., Rowe, S. P., Calais, J., Hofman, M. S., Maurer, T., Schwarzenboeck, S. M., Kratowchil, C., Herrmann, K., & Giesel, F. L. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186767 · Cited by 243
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients
Thoeny, H. C., Triantafyllou, M., Birkhaeuser, F. D., Froehlich, J. M., Vogel, D. W. T., Binser, T., Fleischmann, A., Vermathen, P., & Studer, U. E. (2009) · European Urology · doi:10.1016/j.eururo.2008.12.034 · Cited by 238
PSMA Ligands for PET Imaging of Prostate Cancer
Schwarzenboeck, S. M., Rauscher, I., Bluemel, C., Fendler, W. P., Rowe, S. P., Pomper, M. G., Asfhar-Oromieh, A., Herrmann, K., & Eiber, M. J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191031 · Cited by 223
In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent
Glaus, C., Rossin, R., Welch, M. J., & Bao, G. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900511j · Cited by 209
Ten Things You Might Not Know about Iron Oxide Nanoparticles
Daldrup-Link, H. E. (2017) · Radiology · doi:10.1148/radiol.2017162759 · Cited by 181
Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide
Richards, J. M. J., Semple, S. I. K., MacGillivray, T., Gray, C. D., Langrish, J. P., Williams, M., Dweck, M. R., Wallace, W. A., McKillop, G., Chalmers, R. T. A., et al. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.959866 · Cited by 172
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Freitag, M. T., Radtke, J. P., Hadaschik, B. A., Kopp‐Schneider, A., Eder, M., Kopka, K., Haberkorn, U., Roethke, M. C., Schlemmer, H., & Afshar‐Oromieh, A. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3206-3 · Cited by 163
Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study
Klenk, C., Gawande, R. S., Uslu, L., Khurana, A., Qiu, D., Quon, A. S. W., Donig, J., Rosenberg, J., Luna‐Fineman, S., Moseley, M. E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70021-x · Cited by 156
Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases
Budiharto, T., Joniau, S., Lerut, E., den Bergh, L. V., Mottaghy, F. M., Deroose, C. M., Oyen, R., Ameye, F., Bogaerts, K., Haustermans, K. M., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.015 · Cited by 155
Preliminary Results for Characterization of Pelvic Lymph Nodes in Patients With Prostate Cancer by Diffusion-Weighted MR-Imaging
Eiber, M., Beer, A. J., Holzapfel, K., Tauber, R., Ganter, C., Weirich, G., Krause, B. J., Rummeny, E. J., & Gaa, J. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181bbdc2f · Cited by 153
Engineering Iron Oxide Nanoparticles for Clinical Settings
Cortajarena, A. L., Ortega, D., Ocampo, S. M., Gonzalez-García, A., Couleaud, P., Miranda, R., Belda-Iniesta, C., & Ayuso‐Sacido, Á. (2014) · Nanobiomedicine · doi:10.5772/58841 · Cited by 151
Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection
Briganti, A., Abdollah, F., Nini, A., Suardi, N. R., Andrea Gallina, A., Umberto Capitanio, A., Bianchi, M., Tutolo, M., Passoni, N. M., Salonia, A., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.11.008 · Cited by 149
Detection of Recurrent Prostate Carcinoma withanti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and111In–Capromab Pendetide SPECT/CT
Schuster, D. M., Savir-Baruch, B., Nieh, P. T., Master, V. A., HALKAR, R. K., Rossi, P. J., Lewis, M. M., Nye, J. A., Yu, W., Bowman, F. D., et al. (2011) · Radiology · doi:10.1148/radiol.11102023 · Cited by 147
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 141
Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors
Iv, M., Telischak, N., Feng, D., Holdsworth, S. J., Yeom, K. W., & Daldrup-Link, H. E. (2015) · Nanomedicine · doi:10.2217/nnm.14.203 · Cited by 134
The Value of Magnetic Resonance Imaging for Radiotherapy Planning
Dirix, P. R., Haustermans, K. M., & Vandecaveye, V. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.02.003 · Cited by 132
Nanoparticles Labeled with Positron Emitting Nuclides: Advantages, Methods, and Applications
Liu, Y., & Welch, M. J. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200264c · Cited by 117
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences
Ost, P., Jereczek-Fossa, B. A., van As, N., Zilli, T., Tree, A. C., Henderson, D., Orecchia, R., Casamassima, F., Surgo, A., Miralbell, R., et al. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.04.040 · Cited by 117
PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
Giesel, F. L., Fiedler, H., Stefanova, M., Sterzing, F., Rius, M., Kopka, K., Moltz, J. H., Afshar‐Oromieh, A., Choyke, P. L., Haberkorn, U., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3106-6 · Cited by 116
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer
Triantafyllou, M., Studer, U. E., Birkhäuser, F. D., Fleischmann, A., Bains, L. J., Petralia, G., Christe, A., Froehlich, J. M., & Thoeny, H. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.034 · Cited by 115
Pathways of Lymphatic Spread in Male Urogenital Pelvic Malignancies
Paño, B., Sebastià, C., Buñesch, L., Mestres, J., Salvador, R., Macías, N., & Nicolau, C. (2011) · Radiographics · doi:10.1148/rg.311105072 · Cited by 114
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Westdorp, H., Creemers, J. H. A., van Oort, I. M., Schreibelt, G., Gorris, M. A. J., Mehra, N., Simons, M., de Goede, A. L., van Rossum, M. M., Croockewit, A. J., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0787-6 · Cited by 114
Self-citation
Prostate cancer: diagnosis and staging
Borley, N., & Feneley, M. R. (2008) · Asian Journal of Andrology · doi:10.1038/aja.2008.19 · Cited by 110
The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer
Öbek, C., Doğanca, T., Demirci, E., Ocak, M., Kural, A. R., Yıldırım, A., Yücetaş, U., Demirdağ, Ç., Erdoğan, S. M., & Kabasakal, L. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3752-y · Cited by 105
Radionuclide and hybrid imaging of recurrent prostate cancer
Beer, A. J., Eiber, M. J., Souvatzoglou, M., Schwaiger, M., & Krause, B. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70103-0 · Cited by 104
Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
Fortuin, A. S., Brüggemann, R. J. M., van der Linden, J., Panfilov, I., Israël, B., Scheenen, T. W. J., & Barentsz, J. O. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1471 · Cited by 103
Self-citation
The use of PET/CT in prostate cancer
Li, R., RAVIZZINI, G. C., Gorin, M. A., Maurer, T., Eiber, M. J., Cooperberg, M. R., Mehrdad Alemozaffar, A., Tollefson, M. K., Delacroix, S. E., & Chapin, B. F. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-017-0007-8 · Cited by 110
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
Schwarzenböck, S. M., Souvatzoglou, M., & Krause, B. J. (2012) · Theranostics · doi:10.7150/thno.4008 · Cited by 100
The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis
Woo, S., Suh, C. H., Kim, S. Y., Cho, J. Y., & Kim, S. H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18481 · Cited by 101
Magnetic particle imaging: Introduction to imaging and hardware realization
Buzug, T. M., Bringout, G., Erbe, M., Gräfe, K., Graeser, M., Grüttner, M., Halkola, A., Sattel, T. F., Tenner, W., Wojtczyk, H., et al. (2012) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2012.07.004 · Cited by 99
Whole‐body MRI including diffusion‐weighted imaging (DWI) for patients with recurring prostate cancer: Technical feasibility and assessment of lesion conspicuity in DWI
Eiber, M., Holzapfel, K., Ganter, C., Epple, K., Metz, S., Geinitz, H., Kübler, H. R., Gaa, J., Rummeny, E. J., & Beer, A. J. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22542 · Cited by 94
Contemporary Role of Salvage Lymphadenectomy in Patients with Recurrence Following Radical Prostatectomy
Abdollah, F., Briganti, A., Montorsi, F., Stenzl, A., Stief, C. G., TOMBAL, B. F., Poppel, H. V., & Touijer, K. A. (2014) · European Urology · doi:10.1016/j.eururo.2014.03.019 · Cited by 93
Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: A meta-analysis
Wu, L., Cao, Y., Liao, C., Huang, J., & Gao, F. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.11.027 · Cited by 88
A Matched Control Analysis of Adjuvant and Salvage High-Dose Postoperative Intensity-Modulated Radiotherapy for Prostate Cancer
Ost, P., Troyer, B. D., Fonteyne, V., Oosterlinck, W., & Meerleer, G. D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.039 · Cited by 87
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients
Heck, M. M., Souvatzoglou, M., Retz, M. M., Nawroth, R., Kübler, H. R., Maurer, T., Thalgott, M. K., Gramer, B. M., Weirich, G., Rondak, I., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2634-1 · Cited by 86
Pelvic Nodal Radiotherapy in Patients With Unfavorable Intermediate and High-Risk Prostate Cancer: Evidence, Rationale, and Future Directions
Morikawa, L. K. K., & Roach, M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.074 · Cited by 83
The role of MRI in prostate cancer: current and future directions
Fernandes, M. C., Yıldırım, O., Woo, S., Vargas, H. A., & Hricak, H. (2022) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-022-01006-6 · Cited by 91
Analysis of 300 dentofacial deformities in Hong Kong.
Samman, N., Tong, A. C., Cheung, D. L., & Tideman, H. (1992) · PubMed · Cited by 82
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer
van Leeuwen, F. W. B., Winter, A., van der Poel, H. G., Eiber, M. J., Suardi, N. R., Graefen, M., Wawroschek, F., & Maurer, T. (2019) · Nature Reviews Urology · doi:10.1038/s41585-018-0140-8 · Cited by 81
Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer
Imai, H., Doi, R., Kanazawa, H., Kamo, N., Koizumi, M., Masui, T., Iwanaga, Y., Kawaguchi, Y., Takada, Y., Isoda, H., et al. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0066-5 · Cited by 78
Evaluation of superparamagnetic iron oxide nanoparticles (Endorem®) as a photoacoustic contrast agent for intra‐operative nodal staging
Grootendorst, D. J., Jose, J., Fratila, R. M., Visscher, M., Velders, A. H., ten Haken, B., van Leeuwen, T. G. J. M., Steenbergen, W., Manohar, S., & Ruers, T. J. M. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1498 · Cited by 78
Diagnostic Performance of 68 Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-analysis
Wu, H. M., Xu, T., Wang, X., Yu, Y., Fan, Z.-Y., Li, D.-X., Luo, L., Yang, X.-C., Jiao, W., & Niu, H. (2019) · The World Journal of Men s Health · doi:10.5534/wjmh.180124 · Cited by 80
Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review
Haroon, M. Y., Tahir, M. W., Nawaz, H., Majeed, M. I., & Al‐Saadi, A. A. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102690 · Cited by 68
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
Barar, J., & Omidi, Y. (2014) · Europe PMC (PubMed Central) · doi:10.5681/bi.2014.011 · Cited by 68
Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer
Beer, A. J., Eiber, M. J., Souvatzoglou, M., Holzapfel, K., Ganter, C., Weirich, G., Maurer, T., Kübler, H. R., Wester, H., Gaa, J., et al. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0337-6 · Cited by 67
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
Malaspina, S., Anttinen, M., Taimen, P., Jambor, I., Sandell, M., Rinta-Kiikka, I. C., Kajander, S. A., Schildt, J., Saukko, E., Noponen, T., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05296-1 · Cited by 65
Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
Yuh, B. E., Ruel, N. H., Mejia, R., Wilson, C. M., & Wilson, T. G. (2012) · European Urology · doi:10.1016/j.eururo.2012.01.048 · Cited by 62
MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery—the MA3RS study
McBride, O. M. B., Berry, C., Burns, P., Chalmers, R. T. A., Doyle, B. J., Forsythe, R. O., Garden, O. J., Goodman, K., Graham, C., Hoskins, P. R., et al. (2015) · Open Heart · doi:10.1136/openhrt-2014-000190 · Cited by 60
Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm
Créhange, G., Chen, C. P., Hsu, C. C.-C., Kased, N., Coakley, F. V., Kurhanewicz, J. V., & Roach, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.05.005 · Cited by 60
Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients With Lymph Node Metastases
Fortuin, A. S., Deserno, W. M. L. L. G., Meijer, H. J. M., Jager, G. J., Takahashi, S., Debats, O. A., Reske, S. N., Schick, C., Krause, B. J., van Oort, I. M., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.12.093 · Cited by 59
Self-citation
Imaging biomarkers in prostate cancer: role of PET/CT and MRI
Picchio, M., Mapelli, P., Panebianco, V., Castellucci, P., Incerti, E., Briganti, A., Gandaglia, G., Kirienko, M., Barchetti, F., Nanni, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2982-5 · Cited by 58
Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer
Yakar, D., Debats, O. A., Bomers, J. G. R., Schouten, M. G., Vos, P., van Lin, E. N. J. T., Fütterer, J. J., & Barentsz, J. O. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22790 · Cited by 58
Self-citation
First Results of [11C]choline PET/CT-Guided Secondary Lymph Node Surgery in Patients with PSA Failure and Single Lymph Node Recurrence after Radical Retropubic Prostatectomy
Winter, A., Uphoff, J., Henke, R., & Wawroschek, F. (2010) · Urologia Internationalis · doi:10.1159/000296298 · Cited by 57
Prostate Cancer Nodal Staging: Using Deep Learning to Predict 68Ga-PSMA-Positivity from CT Imaging Alone
Hartenstein, A., Lübbe, F., Baur, A. D. J., Rudolph, M. M., Furth, C., Brenner, W., Amthauer, H., Hamm, B., Makowski, M. R., & Penzkofer, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-60311-z · Cited by 57
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
Wang, Y., Galante, J. R., Haroon, A., Wan, S., Afaq, A., Payne, H. A., Bomanji, J. B., Adeleke, S. M., & Kasivisvanathan, V. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00618-w · Cited by 57
Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy
Ploussard, G., Staerman, F., Pierrevelcin, J., Saad, R., Beauval, J., Morgan Rouprêt, A., Audenet, F., Peyromaure, M., Delongchamps, N. B., Vincendeau, S., et al. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.04.073 · Cited by 55
PET/MRI: Technical Challenges and Recent Advances
Jung, J. H., Choi, Y., & Im, K. C. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0393-1 · Cited by 55
Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges
Thoeny, H. C., Barbieri, S., Froehlich, J. M., Türkbey, B., & Choyke, P. L. (2017) · Radiology · doi:10.1148/radiol.2017161517 · Cited by 53
Lymph node imaging in initial staging of prostate cancer: An overview and update
Zarzour, J. G., Galgano, S. J., McConathy, J., Thomas, J. V., & Rais‐Bahrami, S. (2017) · World Journal of Radiology · doi:10.4329/wjr.v9.i10.389 · Cited by 51
Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
Oh, S. W., & Cheon, G. J. (2018) · Korean Journal of Radiology · doi:10.3348/kjr.2018.19.5.819 · Cited by 50
Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles
Winter, A., Kowald, T., Paulo, T. S., Goos, P., Engels, S., Gerullis, H., Schiffmann, J., Chavan, A., & Wawroschek, F. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173182 · Cited by 47
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Kroenke, M., Wurzer, A. J., Schwamborn, K., Ulbrich, L., Jooß, L., Maurer, T., Horn, T. D., Rauscher, I., Haller, B., Herz, M., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.234906 · Cited by 47
Detection of Lymph Node Metastases by Gadolinium-Enhanced Magnetic Resonance Imaging: Systematic Review and Meta-analysis
Klerkx, W. M., Bax, L., Veldhuis, W. B., Heintz, A. P. M., Mali, W. P. T. M., Peeters, P. H. M., & Moons, K. G. M. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp514 · Cited by 47
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT
Vág, T., Heck, M. M., Beer, A. J., Souvatzoglou, M., Weirich, G., Holzapfel, K., Krause, B. J., Schwaiger, M., Eiber, M. J., & Rummeny, E. J. (2014) · European Radiology · doi:10.1007/s00330-014-3240-8 · Cited by 46
Current Status of Lymph Node Imaging in Bladder and Prostate Cancer
Kiss, B. M., Thoeny, H. C., & Studer, U. E. (2016) · Urology · doi:10.1016/j.urology.2016.02.014 · Cited by 44
Lymphotropic Nanoparticle-enhanced MRI in Prostate Cancer: Value and Therapeutic Potential
Fortuin, A. S., Smeenk, R. J., Meijer, H. J. M., Witjes, A. J., & Barentsz, J. O. (2014) · Current Urology Reports · doi:10.1007/s11934-013-0389-7 · Cited by 43
Self-citation
Validation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer
von Below, C., Daouacher, G., Wassberg, C., Grzegorek, R., Gestblom, C., Sørensen, J., Ahlström, H. K., & Waldén, M. (2016) · Clinical Radiology · doi:10.1016/j.crad.2015.12.001 · Cited by 43
Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer
Bukavina, L., Luckenbaugh, A. N., Hofman, M. S., Hope, T., Kamran, S. C., Murphy, D. G., Yamoah, K., & Ost, P. (2022) · European Urology · doi:10.1016/j.eururo.2022.10.024 · Cited by 43
Ultrasound-guided immunofunctional photoacoustic imaging for diagnosis of lymph node metastases
Dumani, D. S., Sun, I., & Emelianov, S. (2019) · Nanoscale · doi:10.1039/c9nr02920f · Cited by 42
MR/PET: A New Challenge in Hybrid Imaging
Werner, M. K., Schmidt, H., & Schwenzer, N. F. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.12.8724 · Cited by 41
Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients
Meijer, H. J. M., Fortuin, A. S., van Lin, E. N. J. T., Debats, O. A., Witjes, J. A., Kaanders, J. H. A. M., & Barentsz, J. O. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.021 · Cited by 40
Self-citation
Initial prostate cancer diagnosis and disease staging—the role of choline-PET–CT
Mapelli, P., & Picchio, M. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.191 · Cited by 40
Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
Schilham, M. G. M., Zámecnik, P., Privé, B. M., Israël, B., Rijpkema, M., Scheenen, T. W. J., Barentsz, J. O., Nagarajah, J., & Gotthardt, M. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.258541 · Cited by 38
Self-citation
Ferumoxtran-10 Ultrasmall Superparamagnetic Iron Oxide–Enhanced Diffusion-weighted Imaging Magnetic Resonance Imaging for Detection of Metastases in Normal-sized Lymph Nodes in Patients with Bladder and Prostate Cancer: Do We Enter the Era After Extended Pelvic Lymph Node Dissection?
Fortuin, A. S., Meijer, H. J. M., Thompson, L. C., Witjes, J. A., & Barentsz, J. O. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.017 · Cited by 38
Self-citation
Imaging modalities for prostate cancer
Fütterer, J. J., Barentsz, J. O., & Heijmijnk, S. T. W. P. J. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.63 · Cited by 37
Self-citation
Prostate Cancer Imaging
Talab, S. S., Preston, M. A., Elmi, A., & Tabatabaei, S. (2012) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2012.08.004 · Cited by 37
Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer
Motomura, K., Izumi, T., Tateishi, S., Tamaki, Y., Ito, Y., Horinouchi, T., & Nakanishi, K. (2015) · British journal of surgery · doi:10.1002/bjs.10040 · Cited by 36
The Role of Magnetic Resonance Imaging in (Future) Cancer Staging
Scheenen, T. W. J., & Zámecnik, P. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000741 · Cited by 35
Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors
Mouli, S. K., Zhao, L. C., Omary, R. A., & Thaxton, C. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2009.254 · Cited by 35
Focal Salvage MR Imaging–Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up
Bomers, J. G. R., Overduin, C. G., Jenniskens, S. F. M., Cornel, E. B., van Lin, E. N. J. T., Sedelaar, J. P. M., & Fütterer, J. J. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.07.001 · Cited by 34
Self-citation
Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI
Muehe, A. M., Siedek, F., Theruvath, A. J., Seekins, J. M., Spunt, S. L., Pribnow, A. K., Hazard, F. K., Liang, T., & Daldrup-Link, H. E. (2020) · Theranostics · doi:10.7150/thno.40606 · Cited by 34
Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends
Kaewput, C., & Vinjamuri, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102738 · Cited by 36
Non-invasive molecular imaging of prostate cancer lymph node metastasis
Pouliot, F., Johnson, M., & Wu, L. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.04.004 · Cited by 34
Image-guided robotic interventions for prostate cancer
Sridhar, A. N., Hughes‐Hallett, A., Mayer, E. K., Pratt, P., Edwards, P., Yang, G., Darzi, A. W., & Vale, J. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.129 · Cited by 34
PET Imaging of Prostate Cancer Using 11C-Acetate
Czernin, J. G., Benz, M., & Allen-Auerbach, M. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.05.001 · Cited by 34
Molecular and Functional Imaging for Detection of Lymph Node Metastases in Prostate Cancer
Fortuin, A. S., de Rooij, M., Zámecnik, P., Haberkorn, U., & Barentsz, J. O. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713842 · Cited by 33
Self-citation
Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed?
Bhargava, P., RAVIZZINI, G. C., Chapin, B. F., & Kundra, V. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.21905 · Cited by 35

Authors: Heesakkers, R. A., Hövels, A. M., Jager, G. J., van den Bosch, H. C., Witjes, J. A., Raat, H. P., Severens, J. L., Adang, E. M., van der Kaa, C. H., Fütterer, J. J., & Barentsz, J.
Affiliations: Radboud University Medical Center (NL)
Jeroen Bosch Ziekenhuis (NL)
ZorgSaam (NL)
Maastricht University Medical Centre (NL)
Corresponding author: Barentsz, Jelle
ORCID: Hövels, Anke M
Witjes, J Alfred
Raat, Hein PJ
Severens, Johan L
Adang, Eddy MM
Fütterer, Jurgen J
Barentsz, Jelle
Venue: The Lancet Oncology
Publisher: Elsevier BV
Published: 2008-09
Volume: 9
Issue: 9
Pages: 850-856
ISSN: 1470-2045 (ISSN-L)
DOI: 10.1016/s1470-2045(08)70203-1
OpenAlex: W2124586180
Cited by: 307
References: 40
Citations by year: 2026: 2 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 16 · 2019: 21 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 19 · 2014: 21 · 2013: 27 · 2012: 26
FWCI: 19.89
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Oncology (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Funders: Radboud Universiteit
Topics: Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords: prostate cancer, pelvic lymph node metastasis, MR lymphography, ferumoxtran-10, pelvic lymphadenectomy, multidetector computed tomography, diagnostic accuracy, intermediate- and high-risk prostate cancer, fine-needle aspiration, lymph node staging, negative predictive value, sensitivity and specificity, cost-effectiveness, quality of life
MeSH terms: Aged, Aged, 80 and over, Contrast Media, Dextrans, Humans, Iron, Lymph Node Excision, Lymphatic Metastasis, Male, Middle Aged, Oxides, Predictive Value of Tests, Prostatic Neoplasms, Sensitivity and Specificity, Tomography, X-Ray Computed, Echo-Planar Imaging, Ferrosoferric Oxide, Magnetite Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks